- Home
- JSPR vs DSM Comparison
JSPR vs DSM Comparison
Compare JSPR & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPR
- DSM
- Stock Information
- Founded
- JSPR 2018
- DSM 1989
- Country
- JSPR United States
- DSM United States
- Employees
- JSPR N/A
- DSM N/A
- Industry
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- DSM Investment Managers
- Sector
- JSPR Health Care
- DSM Finance
- Exchange
- JSPR Nasdaq
- DSM Nasdaq
- Market Cap
- JSPR 325.7M
- DSM 301.0M
- IPO Year
- JSPR N/A
- DSM N/A
- Fundamental
- Price
- JSPR $22.50
- DSM $5.77
- Analyst Decision
- JSPR Strong Buy
- DSM
- Analyst Count
- JSPR 11
- DSM 0
- Target Price
- JSPR $73.38
- DSM N/A
- AVG Volume (30 Days)
- JSPR 176.2K
- DSM 161.7K
- Earning Date
- JSPR 11-07-2024
- DSM 01-01-0001
- Dividend Yield
- JSPR N/A
- DSM 3.97%
- EPS Growth
- JSPR N/A
- DSM N/A
- EPS
- JSPR N/A
- DSM N/A
- Revenue
- JSPR N/A
- DSM N/A
- Revenue This Year
- JSPR N/A
- DSM N/A
- Revenue Next Year
- JSPR N/A
- DSM N/A
- P/E Ratio
- JSPR N/A
- DSM N/A
- Revenue Growth
- JSPR N/A
- DSM N/A
- 52 Week Low
- JSPR $6.20
- DSM $4.69
- 52 Week High
- JSPR $31.01
- DSM $6.05
- Technical
- Relative Strength Index (RSI)
- JSPR 53.62
- DSM 28.05
- Support Level
- JSPR $20.77
- DSM $5.76
- Resistance Level
- JSPR $23.11
- DSM $6.18
- Average True Range (ATR)
- JSPR 1.59
- DSM 0.05
- MACD
- JSPR -0.01
- DSM -0.03
- Stochastic Oscillator
- JSPR 68.97
- DSM 8.33
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.